Butea superba (red kwao krua)
Also called red kwao krua, red kwao khruea, red gwow kreur, Butea superba Roxb..
Best grade D across 2 graded outcomes Botanical Last checked
The short answer
From 11 sourcesButea superba (red kwao krua) is a Thai tuber marketed as a male potency herb. There is no reliable placebo-controlled evidence that it improves erections: the one placebo trial lost its whole placebo group, and a product that matched sildenafil turned out to contain a sildenafil-type drug. FDA warns that sexual-enhancement products often hide prescription drugs.
Every graded outcome on this page
2 rows · line = participantsKey facts
- Placebo arm collapsed
- In the only randomized placebo trial, every placebo participant dropped out by week 3, leaving only a before-and-after comparison in the 17 men given Butea111
- Adulterated batch
- A Butea product that matched sildenafil was most likely blended with a sildenafil-type drug; a second batch showed no effect versus starch2
- FDA warning
- FDA says many products sold for sexual enhancement are likely contaminated with dangerous hidden ingredients9
- Hormone effects
- A 35-year-old man had raised dihydrotestosterone after a few weeks of Butea capsules; it normalised a week after stopping3
- Animal toxicity
- 90 days of high-dose tuber powder lowered testosterone and raised liver enzymes in male rats4
What it is
Butea superba is a plant of Thailand and India whose tuberous roots, known in Thailand as red kwao krua, are sold as a male potency supplement.
How it works
ProposedForms, side by side
2 forms named in our sources. The rest show what our data holds, and say plainly where it holds nothing yet.
Butea superba (red kwao krua) forms compared
2 forms| 2 forms | Dried tuber powder capsules | Commercial Butea superba products |
|---|---|---|
| Absorption in people | Not studied.11 | Not studied.29 |
| GI tolerance | No changes in blood counts, chemistry or testosterone in 17 men over 3 months (small and uncontrolled).11 | Batches can be adulterated with prescription PDE5 inhibitors; FDA warns this category often hides drugs.29 |
| Studied for | Erectile dysfunction | Sexual enhancement marketing |
- Dried tuber powder capsules
- Commercial Butea superba products
What the human research says
Human trials only, one row per outcome. The form line shows what each trial actually tested. Grades follow our evidence-grading policy.
Trial map
2 graded outcomes, largest study first2 graded outcomes: 1 mixed, 1 no effect. The largest, a 2003 randomized trial of 39 people on erectile function (IIEF-5) with a lost placebo group, found mixed results.
1Erectile function (IIEF-5) with a lost placebo group
Mixed · Grade D · RCT, 39 people, 2003
Thai men aged 30 to 70 with erectile dysfunction for at least 6 months
Dose, result and source| Outcome | Found | People | Study | Who was studied |
|---|---|---|---|---|
| Erectile function (IIEF-5) with a lost placebo group | Mixed | 39 | Grade D · RCT, 2003 | Thai men aged 30 to 70 with erectile dysfunction for at least 6 months |
| Erectile function (IIEF-5) vs sildenafil, then vs starch | No effect | 32 | No-effect grade · Open-label trial, 2010 | Men with organic erectile dysfunction |
Every graded row
2 rowsDGrade DErectile function (IIEF-5) with a lost placebo groupSexual functionUnreliable: no placebo comparisonRCT
n 39 · 2003
Mixed Among men given Butea, 4 of 5 IIEF-5 items improved from baseline and 14 of the 17 men who finished (82.4%) reported some improvement. All placebo participants had dropped out by week 3, so no comparison with placebo was possible. Blood counts, blood chemistry and testosterone did not change.
- Design
- RCT, n = 39, 2003
- Population
- Thai men aged 30 to 70 with erectile dysfunction for at least 6 months
- Form
- Dried Butea superba tuber powder capsules (250 mg) vs tapioca-starch placebo
- Dose
- 1,000 mg/day (500 mg/day for the first 4 days)
- Duration
- 3 months
- Source
- Reference 1 · PubMed 12937809 (opens PubMed)
∅No effectErectile function (IIEF-5) vs sildenafil, then vs starchSexual functionNo effect once adulteration excludedOpen-label trial
n 32 · 2010
No effect In the open phase, 84% responded to the first Butea batch vs 81% to sildenafil. In the double-blind phase the second batch had no effect. The authors concluded the first batch was most likely blended with a PDE5 inhibitor, which the supplier later confirmed.
- Design
- Open-label trial, n = 32, 2010
- Population
- Men with organic erectile dysfunction
- Form
- Butea superba 'natural health' product vs sildenafil 50 mg; responders then received a second Butea batch or starch (double-blind)
- Dose
- 100 mg Butea superba product
- Duration
- Short-term, with a 1-week washout
- Source
- Reference 2 · PubMed 19624593 (opens PubMed)
What the numbers add up to
Each point is worked out from the data and the sources numbered on this page, with the arithmetic shown under it. It adds no new data and is not medical advice.
No reliable human efficacy data
Testosterone claims are not supported in people
Studied doses
Doses used in research, shown against the official limits. They describe the studies, not a recommendation for you.
Studied doses in research, not advice. These are amounts used in research, not personal advice. Your clinician or pharmacist can say what fits you.
Doses studied in human trials
Interactions and safety
Published interactions only: each row cites a source. No row means none was found in our sources, not that a combination is safe.
What Butea superba meets
2 cited rowsMedicines 2
Supplements and foods 0
No supplement rows in our sources.
- Drug label or FDA notice
- Case reports
Choose a medicine or supplement above to read its cited rows here.
Also cited:
Nitrates (for example nitroglycerin)
FDA safety communicationDrug label or FDA notice
Nitrates (for example nitroglycerin): Sexual-enhancement products have contained undeclared sildenafil, which FDA warns may interact with nitrates and lower blood pressure to dangerous levels; one Butea batch tested in a study was adulterated with a PDE5 inhibitor.
Source 10, US Food and Drug Administration (2022); Source 2, BJU Int (2010)
Hormone therapies (testosterone, anti-androgens)
Case reportCase reports
Hormone therapies (testosterone, anti-androgens): Butea superba showed androgenic activity in rats and was linked to raised dihydrotestosterone in one man; use with hormone drugs has not been studied.
Source 3, Indian J Endocrinol Metab (2012); Source 6, J Ethnopharmacol (2009)
Interactions
2 agents| Agent | What the source says | Evidence |
|---|---|---|
| Medicines2 | ||
| Nitrates (for example nitroglycerin) | Sexual-enhancement products have contained undeclared sildenafil, which FDA warns may interact with nitrates and lower blood pressure to dangerous levels; one Butea batch tested in a study was adulterated with a PDE5 inhibitor.102 | FDA safety communication |
| Hormone therapies (testosterone, anti-androgens) | Butea superba showed androgenic activity in rats and was linked to raised dihydrotestosterone in one man; use with hormone drugs has not been studied.36 | Case report |
Check with what you take
Kept on this device onlyAdd what you take. We list every interaction our evidence profiles cite between Butea superba and your picks, and between your picks.
- Loading names…
Add a supplement or medicine you take to check it against Butea superba.
Starting from one medicine? The interaction checker rates how serious each pair is, on a curated list of 19 entries for 11 medicines. This cabinet has no severity rating: it lists every interaction row our supplement pages cite.
Who should be careful
4 groups- People who use nitrates or have heart disease
- Products sold for sexual enhancement can hide sildenafil-type drugs that FDA warns may drop blood pressure dangerously with nitrates, which people with diabetes, high blood pressure, high cholesterol or heart disease often use.1092
- Women, including during pregnancy and breastfeeding
- Butea superba had androgenic effects on the uterus of female rats, and there are no human safety data in women, in pregnancy or during breastfeeding (LactMed has no entry).6
- People with hormone-sensitive conditions
- One man had raised dihydrotestosterone while using Butea capsules, and high-dose rat studies showed testosterone and luteinising hormone changes.347
- People with liver concerns
- High doses raised the liver enzymes ALP and AST in male rats over 90 days.4
Hidden drugs and hormone effects
4 notesProducts in this category are often adulterated.
- FDA warning
- FDA states that many products claiming sexual enhancement are likely contaminated with dangerous hidden ingredients, and that its notification list covers only a small fraction of them.9
- Adulterated study batch
- In a 2010 study, the Butea batch that matched sildenafil was most likely blended with a PDE5 inhibitor, as its supplier later confirmed; a second batch showed no effect.2
- Raised androgen levels
- A man using locally made Butea capsules for hair loss had dihydrotestosterone of 1,512 pg/mL (reference 250 to 990), which returned to normal one week after stopping.3
How to read the label
What to check on the Supplement Facts panel.
How to read the label
2 checksRed vs white kwao krua
Red kwao krua (Butea superba) is a different plant from white kwao krua (Pueraria mirifica), a phytoestrogen herb.11
Frequently asked questions
Short answers to common questions; the numbers link to the sources below.
Common questions
7 answersDoes Butea superba work for erectile dysfunction?
Does it raise testosterone?
Does Butea superba help hair loss?
No trial has tested it. The one published case of a man using Butea capsules for hair loss reported dihydrotestosterone of 1,512 pg/mL, above the reference range, which returned to normal a week after stopping.3
Can women take Butea superba?
There are no human safety data in women. In female rats it had androgenic (male-hormone-like) effects on the uterus.6
Is it safe?
Is Butea superba the same as white kwao krua (Pueraria mirifica)?
No. Red kwao krua is Butea superba, sold for male potency; white kwao krua is Pueraria mirifica, a different plant used as a phytoestrogen herb.11
Why did one study find it as strong as sildenafil?
The batch used was most likely blended with a PDE5 inhibitor, the drug class that includes sildenafil, which the supplier later confirmed.2
Sources
11 sources: trial abstracts, NIH fact sheets and reference databases. Numbers in the text link here.
Sources cited on this page
11 sources- 1Clinical trial of Butea superba, an alternative herbal treatment for erectile dysfunction.RCT Asian J Androl, 2003 · PMID 12937809
- 2The use of Butea superba (Roxb.) compared to sildenafil for treating erectile dysfunction.Open-label trial BJU Int, 2010 · PMID 19624593
- 3Hyperandrogenemia due to ingestion of Butea superba.Observational Indian J Endocrinol Metab, 2012 · PMID 22629537
- 4Androgen disruption and toxicity tests of Butea superba Roxb., a traditional herb used for treatment of erectile dysfunction, in male rats.Animal study Maturitas, 2008 · PMID 18554827
- 5The toxicology of Butea superba, Roxb.Animal study Southeast Asian J Trop Med Public Health, 2002 · PMID 12971499
- 6Androgenic activity of the Thai traditional male potency herb, Butea superba Roxb., in female rats.Animal study J Ethnopharmacol, 2009 · PMID 19010408
- 7Luteinizing hormone reduction by the male potency herb, Butea superba Roxb.Animal study Braz J Med Biol Res, 2010 · PMID 20721473
- 8Rise of herbal and traditional medicine in erectile dysfunction management.Review Curr Urol Rep, 2011 · PMID 21948222
- 9Sexual Enhancement and Energy Product NotificationsSafety communication US Food and Drug Administration, 2026 · fda.gov
- 10Public Notification: JACK’D Sexual Enhancement Liquid contains hidden drug ingredientSafety communication US Food and Drug Administration, 2022 · fda.gov
- 11Clinical trial of Butea superba, an alternative herbal treatment for erectile dysfunction (full text)RCT Asian Journal of Andrology, 2003 · asiaandro.com
What changed
Every dated change to this page: what changed, who made it and why.
Change log
2 entries| Date | Change | Who and why |
|---|---|---|
| who should avoid, FAQ, questions, related | Pregnancy note now covers breastfeeding (no human data; no LactMed entry). Replaced the FAQ item that repeated the page's own "What is" question with red vs white kwao krua, and added FAQ items on hair loss and use by women, page questions and a goal-hub link. PubMed search (all years) found no human trial since 2010 and no meta-analysis; no LiverTox, LactMed, NCCIH or MedlinePlus entry exists, so the interaction list (FDA hidden-drug and hormone cautions) is unchanged. | Writer: Kymata Health EditorialTrigger: A–Z audit against docs/supplements/AUDIT-STANDARD.md |
| all | Initial editorial evidence review (first draft). Every PMID checked against NCBI E-utilities esummary (titles and years taken from the record, none retracted) and the abstract read for each cited row. Studied doses are reported as research doses, not dosing advice. | Writer: Kymata Health EditorialTrigger: new page |
Supplement & Nutrient Encyclopedia. Educational information only; it is not medical advice and does not replace a clinician. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Statements about supplements have not been evaluated by the FDA.